New state laws aim to clarify abortion bans. Doctors say it's not so simple.
Almost three years after the fall of Roe v. Wade made way for near-total abortion bans, state lawmakers are weighing whether to offer more specific guidance about when doctors can perform abortions in a medical crisis.
Texas, Kentucky and Tennessee all passed laws this year ostensibly clarifying the scope of its abortion bans, a reaction to climbing sepsis rates and harrowing stories of patients who have suffered or died preventable deaths. Since June 2022, lawmakers in at least nine states have introduced such bills.
But doctors, attorneys and policy experts say that the laws being enacted will not solve the problems health providers have been forced to navigate since the end of Roe: The risk of being punished has deterred physicians, hospitals and health systems from providing consistent care, even when it is needed.
'The problem with these clarifying laws is they don't expand access under the law, they don't change the definitions, and they don't remove the legislative interference in the practice of medicine,' said Molly Meegan, chief legal officer and general counsel to the American College of Obstetricians and Gynecologists.
In Texas, a bill that awaits Republican Gov. Greg Abbott's signature ostensibly clarifies when the state's near-total abortion ban allows for the procedure, saying explicitly that physicians do not need to wait until a patient is in imminent danger of dying to perform an abortion. The bill also requires training for doctors and lawyers on the state's abortion law.
But lawmakers have made clear that the bill, crafted in consultation with Texas-based health professionals and abortion opponents, does not introduce new exceptions; Texas' ban does not allow for abortions in cases of rape, incest or fatal fetal anomaly. And if enacted, it would codify a Texas Supreme Court decision that found that the state's ban still applied even in cases with complications that could threaten a pregnant person's health.. Such was the case for Dallas woman Kate Cox, who experienced amniotic fluid leaking and cramping — which create the risk of bacterial infection — after discovering a likely-fatal fetal anomaly in her pregnancy.
Some former abortion patients whose lives were endangered because of delayed or denied care, including several who challenged the Texas abortion ban, said they fear Senate Bill 31 may not address situations like theirs.
Amanda Zurawski, who sued the state after being denied an abortion when experiencing a life-threatening condition called preterm premature rupture of membrane, said at a legislative hearing on the bill that it likely doesn't provide the clarity she would have needed.
'It is unclear whether SB 31 would have prevented my trauma and preserved my fertility had it existed in 2022, and I find that problematic,' Zurawski said. She only received care after she developed sepsis.
Clarification bills can have mixed support in legislatures. Local physicians might back tweaks to exemption language if they see it as potentially lifesaving for their patients. Some anti-abortion advocates might also favor changes if the legislation can address certain medical emergencies that they believe fall outside of a state's ban, such as ectopic pregnancies or preterm premature rupture of membranes.
But not all anti-abortion advocates or Republican lawmakers within these statehouses support even a small clarification.
'I think in all these cases, lawmakers are being pulled in different directions by these different constituencies,' said Mary Ziegler, an abortion law historian at the University of California, Davis. 'The bills themselves are kind of muddy, because they're trying to be different things to different people.'
The end result are clarification laws that remain unclear to physicians and their employing hospitals and health systems, who can still face high penalties for violating an abortion ban.
'When the law isn't clear, physicians don't intervene,' Ziegler said. 'You're not going to be willing to gamble your liberty and your medical license on an uncertain interpretation of the law.'
In Kentucky, doctors vocally opposed a Republican-backed bill that supporters said would help health professionals understand when they can provide abortions. Like in Texas, the state's ban only allows abortion when it is necessary to save a pregnant person's life. The clarification bill listed specific conditions that would qualify for an exception to the ban — such as sepsis, hemorrhage or ectopic pregnancy — despite concern from doctors that a delineated list wouldn't be able to predict every possible situation where an abortion might save someone's life.
Democratic Gov. Andy Beshear vetoed the bill in March, calling gaps in the law 'literally a matter of life and death.' The state's legislature, where the GOP holds a supermajority, voted days later to override him.
'It's hard to create this laundry list of, 'This is OK, this is not OK,' because unfortunately, medicine is something with a bunch of gray areas,' said Dr. Caitlin Thomas, an OB-GYN in Louisville.
In Georgia — where pregnant, brain-dead woman Adriana Smith remains on life-support until she can give birth later this summer, and where the death of Amber Thurman was attributed to the confusion created by the state's abortion ban — some lawmakers have asked physicians whether a clarification might allow doctors to provide abortions when the pregnancy threatens a patient's life, possibly by listing specific conditions that qualify for an exception.
'We encouraged them not to, and said that would not be helpful,' said Dr. Neesha Verma, an Atlanta-based OB-GYN. 'The more and more prescriptive you make these laws, the less space there is for clinical judgment.'
Following a case filed by seven Tennessee patients who had been denied abortions under the state's ban, lawmakers in that state passed a law this year meant to clarify that, under the state's ban, abortions could be performed in cases of preterm prelabor rupture of membrane or severe preeclampsia, but that the exception did not include mental health emergencies. Mental health conditions including substance use disorder, depression and confirmed or probably suicide are the largest single cause of pregnancy-related deaths in the state, according to a 2022 report.
The interest in clarifying bans — including from some lawmakers who oppose abortion — 'is a response to where we know the public is and the fact that we know the public is generally supportive of abortion access and also has been presented with these terrible preventable cases since Dobbs,' said Kimya Forouzan, who tracks state policy for the Guttmacher Institute, a nonprofit abortion research organization.
That ambiguity was on display in a Texas case last year. A state judge held that the state's abortion law exception permitted Cox to have an abortion when her doctors discovered the anomaly in her pregnancy. But the state's attorney general, Ken Paxton, swiftly intervened, threatening legal action against any health care provider that performed an abortion on Cox. Cox ultimately left the state to terminate her pregnancy.
Michele Goodwin, a law professor at the University of California, Irvine and author of 'Policing the Womb: Invisible Women and the Criminalization of Motherhood,' said state officials can do more to ensure health providers know their legal rights.
'It would be credible for states' attorneys generals and the prosecutors who are conservative to immediately issue statements of clarity, saying that they are opposed to these kinds of conditions, that they will not prosecute,' she said.
The post New state laws aim to clarify abortion bans. Doctors say it's not so simple. appeared first on The 19th.
News that represents you, in your inbox every weekday. Subscribe to our free, daily newsletter.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
30 minutes ago
- Newsweek
Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Senator Bernie Sanders is leading a new bill to address a key priority of Robert F. Kennedy Jr., who serves as President Donald Trump's Health and Human Services Secretary. Why It Matters Sanders, a Vermont independent, alongside Senator Angus King, a Maine independent, introduced the "End Prescription Drug Ads Now Act," which, if passed, would ban prescription drug advertising on TV, radio, print and digital platforms as well as social media. Critics say these ads contribute to the high price of healthcare while doing little to improve care in the United States, though proponents say the advertisements can improve patients' knowledge of healthcare. Most wealthy countries, with the U.S. and New Zealand being two notable exceptions, ban pharmaceutical drug advertisements. The bill also represents an issue where Sanders, viewed as perhaps the most progressive senator, has found common ground with Kennedy inside the Trump administration, though the secretary has not commented on this bill specifically. What to Know Sanders and King announced the legislation on Thursday, highlighting that the pharmaceutical industry spent more than $5 billion on TV ads in 2024 and that many of these drugs cost more in the U.S. than in other countries that do not allow drug companies to run ads on TV. "The American people are sick and tired of greedy pharmaceutical companies spending billions of dollars on absurd TV commercials pushing their outrageously expensive prescription drugs," Sanders said, describing the fact that the U.S. stands mostly alone in allowing pharmaceutical ads as an "international embarrassment." vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, D.C. vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, director of communications Anna Bahr confirmed to Newsweek his office has reached out to Republicans to join the bill. Bahr pointed to lobbying from the pharmaceutical and health insurance industries as to why the U.S. has not joined other countries in bannign the ads. "Over the past 25 years, the drug companies have spent $8.5 billion on lobbying. Today, they have some 1,800 well-paid lobbyists in Washington, D.C. – including former leaders of the Republican and Democratic parties," she said in a statement to Newsweek. "Unbelievably, that is more than three lobbyists for every member of Congress. During that same period, they have provided over $700 million in campaign contributions. And they are equal opportunity contributors. They contribute heavily to both Republican and Democratic candidates." Secretary Kennedy—as well as Elon Musk, who previously served in Trump's administration—have expressed support for ending pharmaceutical advertising. "Let's get President Trump back in the White House and me to DC so we can ban pharmaceutical advertising," Kennedy wrote in a post to X (formerly Twitter) on November 3, 2024. During his own presidential campaign, Kennedy said he would have issued an executive order ending the advertisements on his first day in office. Newsweek reached out to DHS for comment via the department's press contact form. Caleb Alexander, professor of epidemiology at the Johns Hopkins University Bloomberg School of Public Health, told Newsweek that while a potential ban's impact on drug prices remains uunclear, there would be benefits to ending these advertisements. Pharmaceutical advertisements can drive up "inappropriate demand" for prescription drugs in settings where they may not be needed, he said. "In terms of the potential benefits of banning [direct-to-consumer advertisements], the most immediate and likely is that it would temper demand for products in settings where they may not be needed," Alexander said. The U.S. has "evolved to believe" the benefits of the ads, such as empowering patients to identify health concerns, outweigh the risks, though much of the research on the topic indicates that the benefits may not be worth the drawbacks, he said. What People Are Saying Alexander told Newsweek: "Direct to consumer advertising has been a lightning rod for controversy, and it remains a curious and unique feature of the U.S. marketplace. While a ban on direct advertising may be welcomed by many, it's not going to fundamentally transform the marketplace for prescription drugs in the United States, simply because DTCA is highly concentrated among a small number of products. It may be a reasonable political and public health target, but I think that if you just look at the way the dollars flow, there's vastly more money spent on marketing drugs to prescribers." Senator Angus King wrote in a statement: "The widespread use of direct-to-consumer advertising by pharmaceutical companies drives up costs and doesn't necessarily make patients healthier. The End Prescription Drug Ads Now Act would prohibit direct-to-consumer advertising of pharmaceutical drugs to protect people. This bill is a great step to ensure that patients are getting the best information possible and from the right source: their providers and not biased advertisements." Elon Musk wrote to X in November 2024: "No advertising for pharma." What Happens Next It's unclear whether a majority of senators are also in support of the bill. So far, Democratic Senators Chris Murphy of Connecticut, Peter Welch of Vermont, Jeff Merkley of Oregon and Dick Durbin of Illinois have co-sponsored the bill, according to Sanders' office.
Yahoo
35 minutes ago
- Yahoo
US lawmakers pass tougher penalties for fentanyl traffickers
The US Congress on Thursday passed a bill imposing harsher penalties on fentanyl traffickers, with lawmakers from both parties anxious to crack down on an opioid that has driven an epidemic of deadly overdoses. The Senate-passed bill -- which delivers on a key election pledge of President Donald Trump to get tough on drug smuggling -- was rubber-stamped by the House on a 321-104 vote, with Democrats providing all but one of the no votes. The Justice Department says 75,000 Americans die each year because of fentanyl, making it the number one cause of death for people between the ages of 18 and 34 in the United States. The synthetic opioid is more potent than heroin and much cheaper to produce. "More Americans die of drug overdoses each year than the number of Americans who died in the entirety of the Vietnam War," Republican Senate Majority Leader John Thune said ahead of the vote. The HALT Fentanyl Act places copycat variations of fentanyl -- often sold by traffickers -- on the government's list of most dangerous "Schedule 1" drugs alongside the original substance. Lab-created fentanyl alternatives were reclassified to "Schedule 1" on a temporary basis seven years ago but the vote makes the change permanent. Trump has made halting the flow of fentanyl one of his priorities, even announcing it as a justification for import tariffs on Mexico and Canada. But opponents said the new law -- rather than tackling overdoses -- would simply repeat the mistakes of the so-called "War on Drugs." The Leadership Conference on Civil and Human Rights, a coalition of more than 240 US rights organizations, said in a statement the measure would "exacerbate pretrial detention, mass incarceration, and racial disparities in the prison system." "Beginning in the 1980s, draconian drug laws with harsh mandatory minimums and their resulting enforcement under the banner of the 'war on drugs' fueled skyrocketing prison populations," it said. ft/acb
Yahoo
an hour ago
- Yahoo
US health chief says Sen. Cassidy promised pick on vaccine panel
WASHINGTON (Reuters) -U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said he told U.S. Senator Bill Cassidy that he would allow Cassidy to pick a candidate for a key panel of vaccine advisers. Cassidy, a Republican, serves as chairman the U.S. Senate Health, Education, Labor, and Pensions Committee. "What I told Senator Cassidy is that I would allow him to put one of his candidates on, which we're going to do," Kennedy said on Thursday during an interview on Fox News' "The Story with Martha MacCallum," referring to the vaccine advisory panel. Kennedy on Wednesday named eight members to serve on the U.S. Centers for Disease Control and Prevention's Advisory Committee for Immunization Practices, which advises the agency on who should get the shots after they are approved by the U.S. Food and Drug Administration, after gutting the panel last week.